AI-generated content for informational purposes only. Not financial advice. Always do your own research.

حول

UnitedHealth Group (NYSE: UNH) is the largest healthcare company in the world by revenue and the most valuable health stock by market capitalization, operating through two main divisions: UnitedHealthcare, the nation's largest health insurance provider covering over 50 million members, and Optum, a diversified health services business spanning pharmacy benefits, care delivery, and data analytics. The Optum segment has been a key growth engine, expanding into direct healthcare delivery through physician practices, ambulatory surgery centers, and home health services, creating a vertically integrated healthcare enterprise. UnitedHealth Group is a dominant healthcare investment offering exposure to the full spectrum of health services, with a proven management team, consistent double-digit earnings growth, and a track record of increasing dividends for over a decade.

أسهم الشيخوخة السكانية

UnitedHealth Group هي أكبر شركة رعاية صحية في العالم، حيث تجمع بين أكبر شركة تأمين صحي في الدولة (UnitedHealthcare) مع خدمات الرعاية الصحية من Optum، مستفيدة بشكل مباشر من ديناميكيات الشيخوخة السكانية.

أسهم الرعاية الصحية

UnitedHealth Group هي أكبر شركة رعاية صحية من حيث الإيرادات وعلى أساس القيمة السوقية، حيث تجمع بين أكبر عملية تأمين صحي في الدولة ومع منصة خدمات الرعاية الصحية سريعة النمو Optum لإنشاء مؤسسة رعاية صحية متكاملة رأسياً تمس كل جانب تقريباً من نظام الرعاية الصحية الأمريكي.

Key Financials UNH

السعر $293.19
التغيير (1 يوم) +3.10%
التغيير (30D) -11.18%
التغيير (60D) -8.53%
التغيير (90D) -18.28%
التغيير (180D) -1.65%
التغيير (1Y) -44.41%
التغيير (5Y) -11.05%
P/E Ratio 13.20
EPS (TTM) $22.21
نطاق 52 أسبوعاً $234.60 — $606.36
50-Day MA $321.23
الحجم 10.27M

Data updated Feb 15 · Source: Twelve Data

4.1
2 reviews
Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Claude Opus 4.6
AI Review
3.7/5

UnitedHealth Group, the nation's largest health insurer and parent of Optum's healthcare services empire, has experienced a dramatic decline " down over 44% in the past year from its 52-week high of $606. The sell-off reflects a convergence of headwinds: rising medical costs, regulatory scrutiny, a DOJ investigation, and the tragic shooting of a subsidiary CEO that intensified public backlash against managed care. At a P/E of 13.2x with EPS of $22.21, the stock trades at a significant discount to historical multiples, potentially offering deep value for patient investors. The bull case centers on UNH's dominant market position in Medicare Advantage (directly benefiting from aging demographics), diversified revenue streams through Optum, and a track record of consistent earnings growth. The bear case includes elevated medical loss ratios, political risk around healthcare reform, potential regulatory actions, and questions about whether management can restore credibility. Trading well below its 50-day moving average of $321, momentum remains decidedly negative. However, UNH's structural advantages in serving an aging population and its integrated care model provide a durable competitive moat that makes this selloff worth monitoring closely.

Demographic Exposure
4.7
Growth Potential
3.8
Dividend Reliability
3.5
Financial Stability
3.2
Regulatory Risk
2
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.4/5

UnitedHealth Group remains a dominant force in the healthcare sector, leveraging its integrated model of insurance (UnitedHealthcare) and health services (Optum) to drive long-term growth. The provided financial data indicates the stock is currently trading at a P/E ratio of 12.30, a valuation that appears remarkably attractive relative to historical norms for such a high-quality compounder. While the share price has retreated significantly from its 52-week high of $606.36, creating a bearish technical setup below the 50-day moving average, the company's earnings power remains resilient with an EPS of $22.21. Investors must weigh the attractive valuation against risks like regulatory scrutiny on Medicare Advantage and rising medical loss ratios. However, for value-oriented investors, UNH presents a potential opportunity to acquire a sector leader at a discounted multiple.

Feb 11, 2026
UnitedHealth Group Screenshot

Added: Feb 10, 2026

unitedhealthgroup.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

كيفية اختبار استراتيجية التداول بأثر رجعي: الطرق والأخطاء الشائعة وما تعنيه النتائج فعلاً

كيفية اختبار استراتيجية التداول بأثر رجعي: الطرق والأخطاء الشائعة وما تعنيه النتائج فعلاً

كل متداول لديه استراتيجية تبدو رائعة في رأسه. الاختبار بأثر رجعي هو كيفية معرفتك ما إذا كانت تعمل فعلاً. إليك كيفية اختبار الاستراتيجيات بشكل صحيح والمقاييس التي تهم وسبب أن معظم نتائج الاختبار بأثر رجعي جيدة جداً لتكون حقيقية.